Increased expression of survivin in gastric cancer patients and in first degree relatives

por Yu, J, Leung, W K, Ebert, M P A, Ng, E K W, Go, M Y Y, Wang, H B, Chung, S C S, Malfertheiner, P, Sung, J J Y
Publicado 2002

Novel substituted methylenedioxy lignan suppresses proliferation of cancer cells by inhibiting telomerase and activation of c-myc and caspases leading to apoptosis

por Giridharan, P, Somasundaram, S T, Perumal, K, Vishwakarma, R A, Karthikeyan, N P, Velmurugan, R, Balakrishnan, A
Publicado 2002

Reduced blood flow and oxygenation in SA-1 tumours after electrochemotherapy with cisplatin

por Sersa, G, Krzic, M, Sentjurc, M, Ivanusa, T, Beravs, K, Kotnik, V, Coer, A, Swartz, H M, Cemazar, M
Publicado 2002

Anastrozole (‘Arimidex’) blocks oestrogen synthesis both peripherally and within the breast in postmenopausal women with large operable breast cancer

por Miller, W R, Stuart, M, Sahmoud, T, Dixon, J M
Publicado 2002

A phase III placebo-controlled study in advanced head and neck cancer using intratumoural cisplatin/epinephrine gel

por Werner, J A, Kehrl, W, Pluzanska, A, Arndt, O, Lavery, K M, Glaholm, J, Dietz, A, Dyckhoff, G, Maune, S, Stewart, M E, Orenberg, E K, Leavitt, R D
Publicado 2002

Determinants of formation of aflatoxin-albumin adducts: a seven-township study in Taiwan

por Sun, C-A, Wu, D-M, Wang, L-Y, Chen, C-J, You, S-L, Santella, R M
Publicado 2002

Hypermethylation of the hMLH1 gene promoter in solitary and multiple gastric cancers with microsatellite instability

por Sakata, K, Tamura, G, Endoh, Y, Ohmura, K, Ogata, S, Motoyama, T
Publicado 2002

c-erbB-2 is not a major factor in the development of colorectal cancer

por McKay, J A, Loane, J F, Ross, V G, Ameyaw, M-M, Murray, G I, Cassidy, J, McLeod, H L
Publicado 2002

Methylation of hMLH1 promoter correlates with the gene silencing with a region-specific manner in colorectal cancer

por Deng, G, Peng, E, Gum, J, Terdiman, J, Sleisenger, M, Kim, Y S
Publicado 2002

Expression of uncoupling proteins-1, -2 and -3 mRNA is induced by an adenocarcinoma-derived lipid-mobilizing factor

por Bing, C, Russell, S T, Beckett, E E, Collins, P, Taylor, S, Barraclough, R, Tisdale, M J, Williams, G
Publicado 2002

Inhibition of all-TRANS-retinoic acid metabolism by R116010 induces antitumour activity

por Van heusden, J, Van Ginckel, R, Bruwiere, H, Moelans, P, Janssen, B, Floren, W, van der Leede, B J, van Dun, J, Sanz, G, Venet, M, Dillen, L, Van Hove, C, Willemsens, G, Janicot, M, Wouters, W
Publicado 2002

A fully human anti-Ep-CAM scFv-beta-glucuronidase fusion protein for selective chemotherapy with a glucuronide prodrug

por de Graaf, M, Boven, E, Oosterhoff, D, van der Meulen-Muileman, I H, Huls, G A, Gerritsen, W R, Haisma, H J, Pinedo, H M
Publicado 2002

p53 as a potential predictive factor of response to chemotherapy: feasibility of p53 assessment using a functional test in yeast from trucut biopsies in breast cancer patients

por Bonnefoi, H, Ducraux, A, Movarekhi, S, Pelte, M F, Bongard, S, Lurati, E, Iggo, R
Publicado 2002

Sequential or alternating administration of docetaxel (Taxotere®) combined with FEC in metastatic breast cancer: a randomised phase II trial

por Spielmann, M, Tubiana-Hulin, M, Namer, M, Mansouri, H, Bougnoux, P h, Tubiana-Mathieu, N, Lotz, V, Eymard, J C
Publicado 2002

Pre-treatment nomogram for biochemical control after neoadjuvant androgen deprivation and radical radiotherapy for clinically localised prostate cancer

por Parker, C C, Norman, A R, Huddart, R A, Horwich, A, Dearnaley, D P
Publicado 2002

Anti-angiogenic effects of the thienopyridine SR 25989 in vitro and in vivo in a murine pulmonary metastasis model

por Mah-Becherel, M C M, Céraline, J, Deplanque, G, Chenard, M-P, Bergerat, J-P, Cazenave, J-P, Klein-Soyer, C
Publicado 2002

The level of haemoglobin in anaemic cancer patients correlates positively with quality of life

por Lind, M, Vernon, C, Cruickshank, D, Wilkinson, P, Littlewood, T, Stuart, N, Jenkinson, C, Grey-Amante, P, Doll, H, Wild, D
Publicado 2002

A phase II study of mitomycin C, cisplatin and continuous infusion 5-fluorouracil (MCF) in the treatment of patients with carcinoma of unknown primary site

por Macdonald, A G, Nicolson, M C, Samuel, L M, Hutcheon, A W, Ahmed, F Y
Publicado 2002

CXCR4/CXCL12 expression and signalling in kidney cancer

por Schrader, A J, Lechner, O, Templin, M, Dittmar, K E J, Machtens, S, Mengel, M, Probst-Kepper, M, Franzke, A, Wollensak, T, Gatzlaff, P, Atzpodien, J, Buer, J, Lauber, J
Publicado 2002

Tumour targeting of humanised cross-linked divalent-fab′ antibody fragments: a clinical phase I/II study

por Casey, J L, Napier, M P, King, D J, Pedley, R B, Chaplin, L C, Weir, N, Skelton, L, Green, A J, Hope-Stone, L D, Yarranton, G T, Begent, R H J
Publicado 2002